Dapagliflozin treatment reduced epicardial adipose tissue FDG SUV
Perirenal adipose
RENAL
SUVmax and SUVmean measured in the EAT surrounding the left circumflex artery (Cx) and the roof of the left atrium (RLA) were significantly decreased in the dapagliflozin group compared to the placebo group (p = 0.01 SUVmean for Cx and RLA, p = 0.003 and p = 0.019 SUVmax for Cx and RLA in dapagliflozin group) Fig. Epicardial adipose tissue (EAT) metabolism: SUV max and SUV mean at left circumflex artery level (Cx) and at the roof of the left atrium (RLA) in placebo (No differences were found in perirenal adipose tissue SUV (Fig. Perirenal adipose tissue metabolism (Renal AT): SUV mean (Epicardial adipose tissue FDG uptake: Representative FDG PET/CT scan of a patient of dapagliflozin group showing SUV mean and SUV max at left circumflex artery (CX) at baseline (